Johnson & Johnson (JNJ) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY Guidance
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $231.29 --0%
Revenue Growth %: +5.1%
Financial Fact:
Sales to customers (Note 9): 17.82B
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +5.1%
Financial Fact:
Sales to customers (Note 9): 17.82B
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.70, $0.02 better than the analyst estimate of $2.68. Revenue for the quarter came in at $24.1 billion versus the consensus estimate of $23.61 billion.
GUIDANCE:
Johnson & Johnson sees FY2026 EPS of $11.55, versus the consensus of $11.55. Johnson & Johnson sees FY2026 revenue of $100.8 billion, versus the consensus of $100.65 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
- Waterdrop names Qianfei Chang as independent director
- Evercore ISI Starts Permian Resources Corp (PR) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
